On September 3, Argan rose 8.48% overnight, trading at $445.21 per share. The surge was driven by the company's fiscal second-quarter earnings report released after the prior session's close, which significantly exceeded Wall Street expectations on both the top and bottom lines.
Specifically, Argan reported fiscal Q2 revenue of $384 million, up 61.5% year-over-year and well above the analyst consensus estimate of approximately $301 million. Adjusted earnings per share came in at $3.76, representing a 50.4% increase from $2.50 in the year-ago period, and surpassing the consensus estimate of $2.64 by roughly 42%. This marks the third consecutive quarter of substantial earnings beats, following a Q1 EPS of $3.24 versus $2.31 expected, and a Q4 EPS of $3.47 versus $1.96 expected. The stock had declined 5.05% in the session prior to the earnings release amid investor uncertainty over whether the company could sustain its elevated growth trajectory. The comprehensive beat effectively dispelled those concerns, restoring investor confidence. Earlier this year, JPMorgan upgraded Argan to Overweight with a $550 price target following strong Q4 results, reflecting growing institutional optimism around the company's expanding project backlog.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments